154 episodes

"The Long Run"

Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.

Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

The Long Run with Luke Timmerman Timmerman Report

    • Science

"The Long Run"

Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.

Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

    Ep156: David Liu on New Tools and Techniques for Biology

    Ep156: David Liu on New Tools and Techniques for Biology

    David Liu, professor of chemistry at Harvard University and co-founder of multiple biotech companies, including Beam Therapeutics and Prime Medicine.

    • 1 hr 52 min
    Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's

    Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's

    Valerie Daggett, founder and CEO of Seattle-based AltPep, on early detection and treatment of Alzheimer's.

    • 1 hr 2 min
    Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer

    Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer

    Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.

    • 1 hr 3 min
    Ep153: Rick Young on Studying Gene Expression for Drug Discovery

    Ep153: Rick Young on Studying Gene Expression for Drug Discovery

    Rick Young, professor at MIT and co-founder of Syros Pharmaceuticals, CAMP4 Therapeutics, Omega Therapeutics, and Dewpoint Therapeutics, on studying gene expression for drug discovery.

    • 1 hr 1 min
    Ep152: Jens Eckstein on Investing in Healthy Aging

    Ep152: Jens Eckstein on Investing in Healthy Aging

    Jens Eckstein, investment partner at Hevolution Foundation, on investing in healthy aging.

    • 1 hr 5 min
    Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer

    Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer

    Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer.

    • 1 hr 3 min

Top Podcasts In Science

24 spørgsmål til professoren
Weekendavisen
Videnskab fra vilde hjerner
Niels Bohr Institutet · Københavns Universitet
Hva så?! forklarer alt
Christian Fuhlendorff
Plantejagten
Plantejagten
KRANIEBRUD
Radio4
Periodisk
RAKKERPAK

You Might Also Like

The Readout Loud
STAT
Business Of Biotech
Matt Pillar
Raising Health
Andreessen Horowitz
BioCentury This Week
BioCentury
Biotech 2050 Podcast
Biotech 2050
Biotech Hangout
Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

More by HeadStepper Media

The Workup
Connecticut Health Investigative Team
Strings and Things
Peppergreen Media
About Men Radio
Pedro Rafael Rosado & Christopher Mele
POP | TECH | JAM
J.D. Biersdorfer and Pedro Rafael Rosado